Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Figg

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Pharmacotherapy|May 1, 1997
Pharmacometric analysis of the effect of furosemide on suramin pharmacokineticsS C Piscitelli, A Forrest, R M Lush, et al.
Biomedical Chromatography : BMC|August 29, 2000
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and salivaK S Bauer, R M Lush, M A Rudek, et al.
World Journal of Urology|February 24, 2001
Suramin administration is associated with a decrease in serum calcium levelsM M Walther, N N Rehak, D Venzon, et al.
Cancer Letters|February 26, 1997
In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3S C Dixon, A Zalles, C Giordano, et al.
American Journal of Hematology|April 3, 2001
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3M A Rudek, M Horne, W D Figg, et al.
British Journal of Cancer|May 14, 2008
Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100N F Smith, S D Baker, F J Gonzalez, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 29, 1998
Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancerJ A Feuer, R M Lush, D Venzon, et al.
American Journal of Hematology|February 1, 1996
Severe thrombocytopenia in patients treated with suramin: evidence for an immune mechanism in oneJ F Tisdale, W D Figg, E Reed, et al.
Journal of Clinical Pharmacology|February 1, 1997
Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonistR M Lush, B Meadows, A T Fojo, et al.
Archives of Internal Medicine|May 9, 1994
Hypothyroidism associated with aminoglutethimide in patients with prostate cancerW D Figg, A Thibault, A O Sartor, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Pharmacotherapy|May 1, 1997
Pharmacometric analysis of the effect of furosemide on suramin pharmacokineticsS C Piscitelli, A Forrest, R M Lush, et al.
Biomedical Chromatography : BMC|August 29, 2000
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and salivaK S Bauer, R M Lush, M A Rudek, et al.
World Journal of Urology|February 24, 2001
Suramin administration is associated with a decrease in serum calcium levelsM M Walther, N N Rehak, D Venzon, et al.
Cancer Letters|February 26, 1997
In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3S C Dixon, A Zalles, C Giordano, et al.
American Journal of Hematology|April 3, 2001
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3M A Rudek, M Horne, W D Figg, et al.
British Journal of Cancer|May 14, 2008
Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100N F Smith, S D Baker, F J Gonzalez, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 29, 1998
Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancerJ A Feuer, R M Lush, D Venzon, et al.
American Journal of Hematology|February 1, 1996
Severe thrombocytopenia in patients treated with suramin: evidence for an immune mechanism in oneJ F Tisdale, W D Figg, E Reed, et al.
Journal of Clinical Pharmacology|February 1, 1997
Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonistR M Lush, B Meadows, A T Fojo, et al.
Archives of Internal Medicine|May 9, 1994
Hypothyroidism associated with aminoglutethimide in patients with prostate cancerW D Figg, A Thibault, A O Sartor, et al.
Pageof 14